Mechanical power in pediatric acute respiratory distress syndrome: a PARDIE study.

Autors de IIS La Fe
Autors aliens a IIS La Fe
- Bhalla AK
- Klein MJ
- Emeriaud G
- Kneyber MCJ
- Medina A
- Cruces P
- Diaz F
- Takeuchi M
- Maddux AB
- Mourani PM
- Camilo C
- White BR
- Yehya N
- Pappachan J
- Di Nardo M
- Shein S
- Newth C
- Khemani R
- Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
Abstract
BACKGROUND: Mechanical power is a composite variable for energy transmitted to the respiratory system over time that may better capture risk for ventilator-induced lung injury than individual ventilator management components. We sought to evaluate if mechanical ventilation management with a high mechanical power is associated with fewer ventilator-free days (VFD) in children with pediatric acute respiratory distress syndrome (PARDS). METHODS: Retrospective analysis of a prospective observational international cohort study. RESULTS: There were 306 children from 55 pediatric intensive care units included. High mechanical power was associated with younger age, higher oxygenation index, a comorbid condition of bronchopulmonary dysplasia, higher tidal volume, higher delta pressure (peak inspiratory pressure-positive end-expiratory pressure), and higher respiratory rate. Higher mechanical power was associated with fewer 28-day VFD after controlling for confounding variables (per 0.1 J·min(-1)·Kg(-1) Subdistribution Hazard Ratio (SHR) 0.93 (0.87, 0.98), p = 0.013). Higher mechanical power was not associated with higher intensive care unit mortality in multivariable analysis in the entire cohort (per 0.1 J·min(-1)·Kg(-1) OR 1.12 [0.94, 1.32], p = 0.20). But was associated with higher mortality when excluding children who died due to neurologic reasons (per 0.1 J·min(-1)·Kg(-1) OR 1.22 [1.01, 1.46], p = 0.036). In subgroup analyses by age, the association between higher mechanical power and fewer 28-day VFD remained only in children < 2-years-old (per 0.1 J·min(-1)·Kg(-1) SHR 0.89 (0.82, 0.96), p = 0.005). Younger children were managed with lower tidal volume, higher delta pressure, higher respiratory rate, lower positive end-expiratory pressure, and higher PCO(2) than older children. No individual ventilator management component mediated the effect of mechanical power on 28-day VFD. CONCLUSIONS: Higher mechanical power is associated with fewer 28-day VFDs in children with PARDS. This association is strongest in children < 2-years-old in whom there are notable differences in mechanical ventilation management. While further validation is needed, these data highlight that ventilator management is associated with outcome in children with PARDS, and there may be subgroups of children with higher potential benefit from strategies to improve lung-protective ventilation. TAKE HOME MESSAGE: Higher mechanical power is associated with fewer 28-day ventilator-free days in children with pediatric acute respiratory distress syndrome. This association is strongest in children <2-years-old in whom there are notable differences in mechanical ventilation management.
© 2021. The Author(s).
Dades de la publicació
- ISSN/ISSNe:
- 1364-8535, 1466-609X
- Tipus:
- Article
- Pàgines:
- 2-2
- PubMed:
- 34980228
- Factor d'Impacte:
- 3,218 SCImago ℠
- Quartil:
- Q1 SCImago ℠
CRITICAL CARE BIOMED CENTRAL LTD
Cites Rebudes en Web of Science: 15
Documents
- No hi ha documents
Filiacions
Keywords
- *Critical care; *Mechanical; *Pediatrics; *Ventilator-induced lung injury; *Ventilators
Projectes associats
ESTUDIO MULTICÉNTRICO DE FASE 3, ALEATORIZADO, CON GRUPOS PARALELOS, ENMASCARADO PARA EL INVESTIGADOR, PARA INVESTIGAR LA SEGURIDAD Y LA EFICACIA DE FIDAXOMICINA EN SUSPENSIÓN ORAL O COMPRIMIDOS CADA 12 HORAS, Y VANCOMICINA EN SOLUCIÓN ORAL O CÁPSULAS CADA 6 HORAS DURANTE 10 DÍAS, EN SUJETOS PEDIÁTRICOS CON DIARREA ASOCIADA A CLOSTRIDIUM DIFFICILE.
Investigador Principal: ANA ISABEL PIQUERAS ARENAS
2819-CL-0202 . 2015
ESTUDIO SIMPLE CIEGO, ALEATORIZADO, MULTICÉNTRICO, CON CONTROL ACTIVO PARA EVALUAR LA SEGURIDAD, TOLERABILIDAD, FARMACOCINÉTICA Y EFICACIA DE CEFTAZIDIMA Y AVIBACTAM CUANDO SE PROPORCIONAN CON METRONIDAZOL EN COMPARACIÓN CON MEROPENEM EN NIÑOS DE 3 MESES A MENOS DE 18 AÑOS DE EDAD CON INFECCIONES INTRAABDOMINALES COMPLICADAS (IIACS).
Investigador Principal: EMILIO MONTEAGUDO MONTESINOS
D4280C00015 . 2015
EFICACIA Y SEGURIDAD DE LEVOSIMENDAN EN EL FALLO CARDIACO AGUDO GRAVE EN NIÑOS CRITICOS
Investigador Principal: VICENT MODESTO ALAPONT
LEVOPED1
ESTUDIO ALEATORIZADO CON CONTROL ACTIVO PARA COMPARAR LA EFICACIA Y LA SEGURIDAD DEL ISOFLURANO INHALADO ADMINISTRADO POR EL ANACONDA-S (DISPOSITIVO DE CONSERVACIÓN DE ANESTÉSICO) CON EL MIDAZOLAM INTRAVENOSO PARA LA SEDACIÓN EN PACIENTES PEDIÁTRICOS CON VENTILACIÓN MECÁNICA DE ENTRE 3 Y 17 AÑOS (MENOS DE 18 AÑOS) SED002.
Investigador Principal: JUAN ENCARNACION MARTINEZ
SED002 . 2021